Patient Research Registries
Date Revised: January 15, 2004
Currently Supported by NIAMS
|
Previously Supported by NIAMS
|
Alopecia Areata
National Alopecia Areata Registry
University of Texas M.D. Anderson Cancer Center, Houston, TX
Principal Investigator: Dr. Madeleine Duvic
This registry aims to seek out and classify medical
and family history data for patients with three major forms of alopecia
areata: alopecia areata, alopecia totalis, and alopecia universalis.
Families with multiple affected members will be especially helpful
to further research studies. The project will offer a future central
information source where researchers can obtain statistical data associated
with the disease.
Registry contact: Madeleine Duvic, M.D.
Phone Number: 713-792-5999
Fax Number: 713-794-1491
Email: alopeciaregistry@mdanderson.org
Ankylosing Spondylitis
North American Spondylitis Consortium
University of Texas-Houston Health Science Center, Houston, TX
Principal Investigator: Dr. John D. Reveille
The consortium hopes to learn more about genes that play a role in
the disease. They plan to collect medical information and genetic
material (DNA) from 400 families nationwide in which two or more siblings
have AS. Through genetic typing methods, researchers will search for
genes that may contribute to predisposition of AS, and they also hope
to identify, from newly mapped candidate genes, mutations and their
effect on disease severity.
Registry Contact: Spondylitis Association of America Family Genetic
Research Project
Phone Number: Toll free (888) 777-1594
Antiphospholipid
Syndrome
National Registry on Antiphospholipid
Syndrome
University of North Carolina, Chapel Hill
Principal Investigator: Dr. Robert Roubey
This registry will collect and update clinical, demographic and laboratory
information from patients with antiphospholipid syndrome (APS) and
make it available to researchers and medical practitioners concerned
with diagnosis and treatment. Registry scientists will collect data
on patients with clinical signs of APS and on asymptomatic individuals
who have antibodies but have not yet developed any clinical signs.
Registry contact: Robert A.S. Roubey, M.D.
Phone number: 919-966-0572
Email: apscore@med.unc.edu
Epidermolysis Bullosa
National Epidermolysis Bullosa Registry
c/o Dermatology Associates of Kentucky, Lexington, KY
Principal Investigator: Dr. J. David Fine
The National EB Registry collects information from patients
with EB, characterizes the many different forms of EB and determines risks of various symptoms
associated with the disease. The information is used for research to improve understanding
and provide better treatment of EB. The registry also provides initial diagnostic
testing of patients.
Registry contact: Jo-David Fine, M.D.
Phone Number: 859-354-4444
Email: ebregistry@daklex.com
Website: www.daklex.com
Fibromyalgia
Fibromyalgia Family Study Registry
Case Western Reserve University, Cleveland, OH
Principal Investigator: Dr. Jane Olson
This research registry is aimed at the collection of
multicase Fibromyalgia Syndrome (FMS) pedigrees. It involves the collection
and validation of clinical, demographic, and laboratory data on FMS
patients from families with at least two FMS-affected individuals
and their family members. DNA is also being collected, stored, and
genotyped, so that that genetic linkage studies may be performed.
Families are eligible for participation in this study if at least
two closely related family members have FMS and if at least one of
these has no other major rheumatologic disease.
Registry contact: Dr. Jane Olson
Phone Number: 216-778-4589
Email: ffs@darwin.cwru.edu
Ichthyosis
National Registry for Ichthyosis
and Related Disorders
University of Washington, Seattle, WA
Principal Investigator: Dr. Philip Fleckman
The registry is aimed at searching for basic defects,
improving methods of diagnosis, and developing effective methods of
treatment and prevention. The registry is actively enrolling affected
individuals with ichthyosis (excluding ichthyosis vulgaris), erythrokeratodermas,
Darier Disease, Hailey-Hailey Disease, pachyonychia congenita, the
palmar-plantar keratodermas, and extensive epidermal nevi. To date,
572 individuals have been enrolled. Serum cholesterol sulfate and
fibroblast fatty aldehyde dehydrogenase testing as means of confirming
X-linked recessive ichthyosis and Sjogren-Larsson Syndrome, respectively,
as well as selected molecular diagnostic tests, are available at no
charge where indicated.
Registry contacts: Philip Fleckman, M.D. or Geoff Hamill,
R.N.
Phone Number: 1-800-595-1265
Email: ichreg@u.washington.edu
Website: www.skinregistry.org
Juvenile Dermatomyositis
New Onset Juvenile Dermatomyositis
Registry
Children's Memorial Hospital, Chicago, IL
Principal Investigator: Dr. Lauren Pachman
The Research Registry for New Onset Juvenile Dermatomyositis
was awarded in September of 1995. The purpose of the Registry is to
collect, characterize and make available to the research community
cases of newly onset juvenile dermatomyositis (JDMS) and investigate
geographic and seasonal clustering of new cases. JDMS is an extremely
rare autoimmune diseases of childhood characterized by the development
of an abnormal skin rash, inflammation of skeletal muscle and vasculopathy.
Constitutional symptoms are common, the cause of the disease is not
known and there is no available cure.
Registry contacts: Dr. Lauren Pachman
Phone Number: 1-888-719-8098
FAX Number: 773-880-4179
Email: kabbott@childrensmemorial.org
Juvenile Rheumatoid Arthritis
Research Registry for Juvenile Rheumatoid Arthritis
(JRA)
Children's Hospital Medical Center,Cincinnati, OH
Principal Investigator: Dr. David N. Glass
Co-Principal Investigator: Dr. Edward Giannini
The primary objective of the Juvenile Rheumatoid Arthritis
Registry is the continued support of the registry function with a
focus on multicase families with affected sibling pairs, and the development
of a related genomics program to identify all of the genes for susceptibility.
DNA will be obtained and stored on all registry patients and family
members. Genome-wide screens will be carried out on these DNA in conjunction
with collaborators from Stanford and Wake Forest Universities.
Registry contact: Edith Shear
Phone Number: 1-800-559-7011
Fax Number: 1-513-636-5990
Lupus
Lupus Registry and Repository
Oklahoma Medical Research Foundation, Oklahoma City, OK
Principal Investigator: Dr. John Harley
The objective of this registry is to support a core facility
dedicated to the collection and characterization of multiplex lupus
pedigrees. Clinical information, genotypes at over 300 loci, and family
relationship structure are available from 303 pedigrees containing 1,832
family members. An additional 50 pedigrees are made available each succeeding
year. Limited amounts of DNA, plasma, and serum are also available from
these pedigrees. Investigators interested in using these data or materials
should visit the website and/or contact Dr. Harley (Oklahoma Medical
Research Foundation, 825 N.E. 13th Street, Oklahoma City,
OK 73104).
Registry contact: John B. Harley, M.D., Ph.D.
Phone Number: 888-655-8787
Fax Number: 405-271-3045
Email: john-harley@omrf.ouhsc.edu
Website: www.omrf.ouhsc.edu/lupus
Muscular Dystrophy
National Registry for Myotonic Dystrophy
and Facioscapulohumeral Dystrophy Patients and Family Members
University of Rochester, Rochester, N.Y.
Principal Investigator: Richard Moxley III, M.D.
This registry aims to seek out and classify patients
with clinically diagnosed forms of myotonic dystrophy (DM) and facioscapulohumeral
dystrophy (FSHD). The registry will store their medical and family
history data. It will serve as a central information source where
researchers can obtain data for analysis associated with these diseases.
Registry Contact: Lynn Cos, R.N., C.C.R.C.
Phone Number: 716-275-7680
Fax Number: 212-598-6449
Email: lynn_cos@urmc.rochester.edu
Neonatal Lupus
Research Registry for Neonatal Lupus
Hospital for Joint Diseases, New York, NY
Principal Investigator: Dr. Jill P. Buyon
Given the rarity of this fetal and neonatal disease,
which most commonly involves the heart and skin, a central repository
of patient information, sera, and DNA was established. The registry
provides material for basic research on the causes of this disease.
It is hoped that the registry will facilitate improved methods of
diagnosis, as well as prevention and treatment. Information from the
registry forms the basis of family counseling and tracks important
data such as recurrence rates in subsequent pregnancies. At the present
time there are 247 mothers and their 287 affected children enrolled.
The registry welcomes new referrals and expects to continue enrollment
until at least September 2004. Investigators interested in obtaining
information or patient materials for basic or clinical research are
encouraged to submit a brief protocol.
Registry Contacts: Dr. Jill P. Buyon or Peg Katholi
Phone Number: 212-598-6514
Fax Number: 212-598-6449
Email: jbuyonic@aol.com
Rheumatoid Arthritis
Rheumatoid Arthritis in African Americans Registry
University of Alabama at Birmingham
Principal Investigator: Dr. Larry Moreland
This registry, Consortium for the Longitudinal Evaluations
of African Americans with Early Rheumatoid Arthritis (CLEAR), aims
to collect clinical and x-ray data and DNA to help scientists analyze
genetic and nongenetic factors that might predict disease course and
outcomes of rheumatoid arthritis. Academic centers in the southeast
United States will recruit African Americans to join the registry.
Registry contacts:
Jacqueline Wyatt
Phone number: 205-975-8091
Email: jacqueline.wyatt@ccc.uab.edu
or
Selena Luckett
Phone number: 205-934-7427
Email: selena.luckett@ccc.uab.edu
Fax number: 205-975-5554
Genetics of Rheumatoid Arthritis Registry
North Shore University Hospital, Manhasset, NY
Principal Investigator: Dr. Peter K. Gregersen
This is a national registry and repository dedicated
to the collection and characterization of sibling pairs with Rheumatoid
Arthritis (RA). The goal of the registry is to collect at least 1,000
families in which two or more siblings are affected with rheumatoid
arthritis. The underlying scientific goal is to search for genes which
predispose to rheumatoid arthritis with the ultimate goal of understanding
the cause of this disease, leading to better diagnosis and treatments.
Each participant with rheumatoid arthritis is visited by a study coordinator
at his or her doctor's office or other location convenient for the
participant. An interview and brief physical exam will be performed,
and a blood specimen obtained. In addition, a hand Xray will be done
if one is not available within the last 2 years. Blood samples will
be requested from the parents (if available) of the participating
rheumatoid arthritis patients. As of May 2000, over 750 families have
agreed to participate in this study. For a family to participate in
the study, the following criteria must be met:
-
Two or more siblings with rheumatoid arthritis in
the family
-
At least one sibling with documented erosions on
hand Xrays
-
At least one sibling with onset of rheumatoid arthritis
between the ages of 18 and 60.
Registry contact: Dr. Peter Gregersen
Phone Number: 1-800-382-4827
Email: narac@nshs.edu
Website: www.medicine.ucsf.edu/divisions/rheum/narac
Scleroderma
Scleroderma Registry
University of Texas Health Science Center, Houston, TX
Principal Investigator: Dr. Maureen Mayes
The aim of the registry is to identify cases of systemic
sclerosis; verify all diagnoses; establish a computer database; provide
a continuous update of the prevalence, incidence, and mortality rates
of scleroderma in this population; and establish prospectively the
average annual mortality. A major focus of the registry is to establish
a cohort of incident cases for early intervention trials and genetic
studies, as well as for basic science and other clinical and epidemiological
studies.
Registry Contact: Dr. Maureen D. Mayes
Phone Number: 800-736-6864 or 713-500-7196
Fax Number: 713-500-0723